FDA data Registry peer set 2 peers

Alternatives to budesonide/formoterol

2 same-class SPL records vs budesonide/formoterol - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Symbicort

Corticosteroid / Long-Acting Beta-2 Agonist Combination Prescription 2 alternatives found

About budesonide/formoterol

Symbicort is a combination medicine that contains a steroid and a long-acting bronchodilator. It helps to control asthma and COPD symptoms.

Used for: Symbicort is used to treat asthma in people 6 years and older. It can help control asthma long-term. Symbicort 160/4.5 is also used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps to improve airflow and reduce flare-ups.

2 Corticosteroid / Long-Acting Beta-2 Agonist Combination peers (wide set)

Compare budesonide/formoterol vs fluticasone/salmeterol side-by-side →

budesonide/formoterol vs fluticasone/salmeterol & fluticasone/vilanterol · FAERS reaction fields

FAERS top-reaction field "Difficulty breathing" shows the widest count spread between budesonide/formoterol and fluticasone/salmeterol, fluticasone/vilanterol in this extract (6,363-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect budesonide/formoterol fluticasone/salmeterolfluticasone/vilanterol
Difficulty breathing 6,363 - -
Asthma 4,697 - -
Tiredness 3,354 - -
Cough 3,164 - -
Headache 2,978 - -
Condition worsened 2,696 - -
Diarrhea 2,696 - -
Nausea 2,621 - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

budesonide/formoterol peer mix vs class inventory

Peer mix

0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Corticosteroid / Long-Acting Beta-2 Agonist Combination: 3 drugs.

Frequently Asked Questions

What same-class SPL records sit beside budesonide/formoterol?
This registry lists 2 Corticosteroid / Long-Acting Beta-2 Agonist Combination medication records beside budesonide/formoterol, including fluticasone/salmeterol, fluticasone/vilanterol. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Corticosteroid / Long-Acting Beta-2 Agonist Combination peer set (2 records)

budesonide/formoterol (Symbicort) sits in a wide Corticosteroid / Long-Acting Beta-2 Agonist Combination peer set (2 of 2 class peers shown). Labeled indication field for budesonide/formoterol: Symbicort is used to treat asthma in people 6 years and older.

Top FAERS reaction fields for budesonide/formoterol total 33,524 reports across 10 reactions, set beside fluticasone/salmeterol, fluticasone/vilanterol. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full budesonide/formoterol profile →

Field note for budesonide/formoterol: see also the generic vs brand label guide when reading Symbicort SPL strings.